Specialty VBC Models

Specialty VBC is shifting from broad primary-care attribution toward tighter condition-specific networks and specialist accountability, with CMS under the Trump administration proposing updates to the Ambulatory Specialty Model for heart failure while market commentary pushes payers to define “high-value” kidney networks around measurable outcomes, avoidable utilization, and total cost performance. Kidney care remains the most active test case: investment in CKD/ESRD management, connected data, and AI infrastructure is rising, but persistent hospital cost pressure suggests many interventions are still too late-stage or insufficiently integrated with upstream nephrology, primary care, and payer network design. For ACOs and payers, the strategic tension is whether specialty models become complementary overlays that reduce avoidable admissions and progression risk—or competing accountability structures that fragment attribution, incentives, and shared-savings economics across cardiology, nephrology, and primary care partners ([ACC on CMS ambulatory specialty HF updates](https://news.google.com/rss/articles/CBMiwgFBVV95cUxORUh5aWlZS0dGV1htVmQ0NVU1SGVFSmVValJLY1dnclZseDdQWkw2Rjljd2poWk80OTdid2t3cWd4b3IyaGdCM3VuUzdZYXNuYUJyT3FiMjJUYjh5c3R5d3dkQllQWWR1RnVUVE5YbDgx